Mesa Laboratories, Inc. (MLAB)
136.06
-6.17
(-4.34%)
USD |
NASDAQ |
Oct 06, 16:00
135.30
-0.76
(-0.56%)
Pre-Market: 08:49
Mesa Laboratories Total Liabilities (Quarterly) : 230.46M for June 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 230.46M |
| March 31, 2026 | 241.50M |
| December 31, 2025 | 248.16M |
| September 30, 2025 | 251.88M |
| June 30, 2025 | 263.25M |
| March 31, 2025 | 273.52M |
| December 31, 2024 | 281.93M |
| September 30, 2024 | 292.65M |
| June 30, 2024 | 289.63M |
| March 31, 2024 | 301.40M |
| December 31, 2023 | 338.81M |
| September 30, 2023 | 249.43M |
| June 30, 2023 | 254.89M |
| March 31, 2023 | 268.35M |
| December 31, 2022 | 275.78M |
| September 30, 2022 | 282.00M |
| June 30, 2022 | 305.38M |
| March 31, 2022 | 313.57M |
| December 31, 2021 | 325.38M |
| September 30, 2021 | 209.68M |
| June 30, 2021 | 213.49M |
| March 31, 2021 | 195.25M |
| December 31, 2020 | 208.84M |
| September 30, 2020 | 196.52M |
| June 30, 2020 | 194.50M |
| Date | Value |
|---|---|
| March 31, 2020 | 189.10M |
| December 31, 2019 | 189.30M |
| September 30, 2019 | 163.31M |
| June 30, 2019 | 40.62M |
| March 31, 2019 | 45.46M |
| December 31, 2018 | 50.57M |
| September 30, 2018 | 53.38M |
| June 30, 2018 | 56.01M |
| March 31, 2018 | 64.74M |
| December 31, 2017 | 73.33M |
| September 30, 2017 | 68.70M |
| June 30, 2017 | 67.99M |
| March 31, 2017 | 73.91M |
| December 31, 2016 | 76.73M |
| September 30, 2016 | 75.98M |
| June 30, 2016 | 74.40M |
| March 31, 2016 | 76.07M |
| December 31, 2015 | 74.47M |
| September 30, 2015 | 76.94M |
| June 30, 2015 | 40.80M |
| March 31, 2015 | 43.84M |
| December 31, 2014 | 44.46M |
| September 30, 2014 | 42.50M |
| June 30, 2014 | 43.89M |
| March 31, 2014 | 33.20M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Lifecore Biomedical, Inc. | 213.41M |
| Repligen Corp. | 838.15M |
| Bio-Techne Corp. | 570.77M |
| Codexis, Inc. | 87.10M |
| MetaStat, Inc. | -- |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 419.22M |
| Shareholders Equity (Quarterly) | 188.76M |
| Debt to Equity Ratio | 0.8548 |
| Current Ratio | 1.794 |
| Net Debt Paydown Yield | 1.17% |